Естонія - естонська - Ravimiamet

accord healthcare b.v. - rasagiliin - tablett - 1mg 28tk; 1mg 112tk; 1mg 100tk; 1mg 60tk; 1mg 10tk; 1mg 56tk

Естонія - естонська - Ravimiamet

sandoz pharmaceuticals d.d. - rasagiliin - tablett - 1mg 28tk; 1mg 98tk; 1mg 10tk; 1mg 100tk

Естонія - естонська - Ravimiamet

teva b.v. - rasagiliin - tablett - 1mg 28tk; 1mg 7tk; 1mg 30tk; 1mg 10tk; 1mg 100tk; 1mg 112tk

Естонія - естонська - Ravimiamet

krka d.d. novo mesto - rasagiliin - tablett - 1mg 60tk; 1mg 28tk; 1mg 14tk; 1mg 84tk; 1mg 30tk; 1mg 10tk; 1mg 56tk

Естонія - естонська - Ravimiamet

medochemie limited - rasagiliin - tablett - 1mg 28tk; 1mg 7tk; 1mg 60tk; 1mg 10tk; 1mg 100tk

Естонія - естонська - Ravimiamet

pharmaswiss ceska republika s.r.o. - rasagiliin - tablett - 1mg 30tk

Європейський Союз - естонська - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripp, inimene - vaktsiinid - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Естонія - естонська - Ravimiamet

casen recordati s.l. - naatriumpikosulfaat+magneesiumoksiid+sidrunhape - suukaudse lahuse pulber kotikeses - 10mg+3,5g+10,97g 100tk; 10mg+3,5g+10,97g 500tk

Європейський Союз - естонська - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Європейський Союз - естонська - EMA (European Medicines Agency)

merck sharp & dohme b.v. - gefapixant - cough - köha ja külmad preparaadid - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.